258 related articles for article (PubMed ID: 21732714)
1. Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?
Marchetti C; Marie H
Rev Neurosci; 2011; 22(4):373-402. PubMed ID: 21732714
[TBL] [Abstract][Full Text] [Related]
2. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
[TBL] [Abstract][Full Text] [Related]
3. APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy.
Breyhan H; Wirths O; Duan K; Marcello A; Rettig J; Bayer TA
Acta Neuropathol; 2009 Jun; 117(6):677-85. PubMed ID: 19387667
[TBL] [Abstract][Full Text] [Related]
4. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
[TBL] [Abstract][Full Text] [Related]
5. Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: a multi-electrode array study.
Chong SA; Benilova I; Shaban H; De Strooper B; Devijver H; Moechars D; Eberle W; Bartic C; Van Leuven F; Callewaert G
Neurobiol Dis; 2011 Dec; 44(3):284-91. PubMed ID: 21807097
[TBL] [Abstract][Full Text] [Related]
6. Cortical plasticity in Alzheimer's disease in humans and rodents.
Battaglia F; Wang HY; Ghilardi MF; Gashi E; Quartarone A; Friedman E; Nixon RA
Biol Psychiatry; 2007 Dec; 62(12):1405-12. PubMed ID: 17651702
[TBL] [Abstract][Full Text] [Related]
7. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
[TBL] [Abstract][Full Text] [Related]
8. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
[TBL] [Abstract][Full Text] [Related]
9. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
García-Mesa Y; López-Ramos JC; Giménez-Llort L; Revilla S; Guerra R; Gruart A; Laferla FM; Cristòfol R; Delgado-García JM; Sanfeliu C
J Alzheimers Dis; 2011; 24(3):421-54. PubMed ID: 21297257
[TBL] [Abstract][Full Text] [Related]
11. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
12. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
13. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
14. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
[TBL] [Abstract][Full Text] [Related]
15. Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice.
West MJ; Bach G; Søderman A; Jensen JL
Neurobiol Aging; 2009 Nov; 30(11):1756-76. PubMed ID: 18336954
[TBL] [Abstract][Full Text] [Related]
16. Synaptic plasticity in animal models of early Alzheimer's disease.
Rowan MJ; Klyubin I; Cullen WK; Anwyl R
Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):821-8. PubMed ID: 12740129
[TBL] [Abstract][Full Text] [Related]
17. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H
Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567
[TBL] [Abstract][Full Text] [Related]
18. Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease.
Faure A; Verret L; Bozon B; El Tannir El Tayara N; Ly M; Kober F; Dhenain M; Rampon C; Delatour B
Neurobiol Aging; 2011 Mar; 32(3):407-18. PubMed ID: 19398247
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities.
Houeland G; Romani A; Marchetti C; Amato G; Capsoni S; Cattaneo A; Marie H
J Neurosci; 2010 Sep; 30(39):13089-94. PubMed ID: 20881126
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease.
Odero GL; Oikawa K; Glazner KA; Schapansky J; Grossman D; Thiessen JD; Motnenko A; Ge N; Martin M; Glazner GW; Albensi BC
Neuroscience; 2010 Aug; 169(1):532-43. PubMed ID: 20399254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]